We are live on ! Find out more
PASG icon

Passage Bio
PASG

48 hedge funds and large institutions have $21.3M invested in Passage Bio in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.1% less ownership

Funds ownership: 3.05% → 2.95% (-0.1%)

11% less funds holding

Funds holding: 54 → 48 (-6)

32% less capital invested

Capital invested by funds: $31.4M → $21.3M (-$10.1M)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
48
Holders Change
-6
Holders Change %
-11.11%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
14
Reduced
13
Closed
6
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$2K

Top Buyers

1
EAM
Erste Asset Management
Austria
+$164K
2
BCM
Bridgeway Capital Management
Texas
+$96.1K
3
TCM
Tang Capital Management
California
+$82.1K
4
Morgan Stanley
Morgan Stanley
New York
+$54K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$21.3K

Top Sellers

1
LCM
Lynx1 Capital Management
Puerto Rico
-$803K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$102K
3
FLSM
Frazier Life Sciences Management
California
-$75.4K
4
Millennium Management
Millennium Management
New York
-$74.8K
5
AC
Annandale Capital
Texas
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$6.66M – – –
VVM
2
Versant Venture Management
California
$3.26M – – –
NLVP
3
New Leaf Venture Partners
New York
$1.65M – – –
EAM
4
Erste Asset Management
Austria
$1.55M +$164K +10,000 +9%
BCM
5
BML Capital Management
Indiana
$1.35M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.33M – – –
FLSM
7
Frazier Life Sciences Management
California
$1.16M -$75.4K -4,589 -5%
BlackRock
8
BlackRock
New York
$666K -$35.2K -2,145 -4%
Renaissance Technologies
9
Renaissance Technologies
New York
$654K +$12.6K +765 +2%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$396K +$21.3K +1,294 +4%
BCM
11
Bridgeway Capital Management
Texas
$333K +$96.1K +5,850 +30%
AI
12
Acuitas Investments
Washington
$275K -$16 -1 -0%
TCM
13
Tang Capital Management
California
$263K +$82.1K +5,000 +33%
WMSA
14
Weiss Multi-Strategy Advisers
New York
$242K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$219K +$230 +14 +0.1%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$158K -$6.16K -375 -3%
Two Sigma Investments
17
Two Sigma Investments
New York
$150K -$25.9K -1,580 -12%
LCM
18
Lynx1 Capital Management
Puerto Rico
$125K -$803K -48,861 -84%
Morgan Stanley
19
Morgan Stanley
New York
$116K +$54K +3,286 +59%
RC
20
RBF Capital
California
$94K – – –
State Street
21
State Street
Massachusetts
$81.5K – – –
Millennium Management
22
Millennium Management
New York
$76.6K -$74.8K -4,552 -44%
FT
23
Fiduciary Trust
Massachusetts
$75.7K – – –
Citadel Advisors
24
Citadel Advisors
Florida
$68.1K +$14K +853 +20%
PFCS
25
Pale Fire Capital SE
Czech Republic
$64.9K – – –
1
2 3

PASG Hedge Fund Activity: Q3 2023 in Review

48 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2023, worth a combined $21.3M — down 32% from $31.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PASG and 1 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Erste Asset Management, adding an estimated $164K. The largest seller was Lynx1 Capital Management, cutting an estimated $803K.

  • 48 institutional investors held Passage Bio (PASG) as of Q3 2023, down from 54 in Q2 2023.
  • Funds reported $21.3M of Passage Bio stock for Q3 2023, down 32% quarter-over-quarter.
  • 1 fund opened new Passage Bio positions in Q3 2023 and 6 closed out, a net change of -5 holders.
  • The largest Passage Bio buyer in Q3 2023 was Erste Asset Management, an estimated $164K added.
  • The largest Passage Bio seller in Q3 2023 was Lynx1 Capital Management, an estimated $803K sold.

Based on aggregated 13F filings for Q3 2023.